Cargando…

Distinct Hepatic Macrophage Populations in Lean and Obese Mice

Obesity is a complex metabolic disorder associated with the development of non-communicable diseases such as cirrhosis, non-alcoholic fatty liver disease, and type 2 diabetes. In humans and rodents, obesity promotes hepatic steatosis and inflammation, which leads to increased production of pro-infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayoral Monibas, Rafael, Johnson, Andrew M. F., Osborn, Olivia, Traves, Paqui G., Mahata, Sushil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138231/
https://www.ncbi.nlm.nih.gov/pubmed/27999564
http://dx.doi.org/10.3389/fendo.2016.00152
_version_ 1782472027734540288
author Mayoral Monibas, Rafael
Johnson, Andrew M. F.
Osborn, Olivia
Traves, Paqui G.
Mahata, Sushil K.
author_facet Mayoral Monibas, Rafael
Johnson, Andrew M. F.
Osborn, Olivia
Traves, Paqui G.
Mahata, Sushil K.
author_sort Mayoral Monibas, Rafael
collection PubMed
description Obesity is a complex metabolic disorder associated with the development of non-communicable diseases such as cirrhosis, non-alcoholic fatty liver disease, and type 2 diabetes. In humans and rodents, obesity promotes hepatic steatosis and inflammation, which leads to increased production of pro-inflammatory cytokines and acute-phase proteins. Liver macrophages (resident as well as recruited) play a significant role in hepatic inflammation and insulin resistance (IR). Interestingly, depletion of hepatic macrophages protects against the development of high-fat-induced steatosis, inflammation, and IR. Kupffer cells (KCs), liver-resident macrophages, are the first-line defense against invading pathogens, clear toxic or immunogenic molecules, and help to maintain the liver in a tolerogenic immune environment. During high fat diet feeding and steatosis, there is an increased number of recruited hepatic macrophages (RHMs) in the liver and activation of KCs to a more inflammatory or M1 state. In this review, we will focus on the role of liver macrophages (KCs and RHMs) during obesity.
format Online
Article
Text
id pubmed-5138231
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51382312016-12-20 Distinct Hepatic Macrophage Populations in Lean and Obese Mice Mayoral Monibas, Rafael Johnson, Andrew M. F. Osborn, Olivia Traves, Paqui G. Mahata, Sushil K. Front Endocrinol (Lausanne) Endocrinology Obesity is a complex metabolic disorder associated with the development of non-communicable diseases such as cirrhosis, non-alcoholic fatty liver disease, and type 2 diabetes. In humans and rodents, obesity promotes hepatic steatosis and inflammation, which leads to increased production of pro-inflammatory cytokines and acute-phase proteins. Liver macrophages (resident as well as recruited) play a significant role in hepatic inflammation and insulin resistance (IR). Interestingly, depletion of hepatic macrophages protects against the development of high-fat-induced steatosis, inflammation, and IR. Kupffer cells (KCs), liver-resident macrophages, are the first-line defense against invading pathogens, clear toxic or immunogenic molecules, and help to maintain the liver in a tolerogenic immune environment. During high fat diet feeding and steatosis, there is an increased number of recruited hepatic macrophages (RHMs) in the liver and activation of KCs to a more inflammatory or M1 state. In this review, we will focus on the role of liver macrophages (KCs and RHMs) during obesity. Frontiers Media S.A. 2016-12-06 /pmc/articles/PMC5138231/ /pubmed/27999564 http://dx.doi.org/10.3389/fendo.2016.00152 Text en Copyright © 2016 Mayoral Monibas, Johnson, Osborn, Traves and Mahata. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Mayoral Monibas, Rafael
Johnson, Andrew M. F.
Osborn, Olivia
Traves, Paqui G.
Mahata, Sushil K.
Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title_full Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title_fullStr Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title_full_unstemmed Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title_short Distinct Hepatic Macrophage Populations in Lean and Obese Mice
title_sort distinct hepatic macrophage populations in lean and obese mice
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138231/
https://www.ncbi.nlm.nih.gov/pubmed/27999564
http://dx.doi.org/10.3389/fendo.2016.00152
work_keys_str_mv AT mayoralmonibasrafael distincthepaticmacrophagepopulationsinleanandobesemice
AT johnsonandrewmf distincthepaticmacrophagepopulationsinleanandobesemice
AT osbornolivia distincthepaticmacrophagepopulationsinleanandobesemice
AT travespaquig distincthepaticmacrophagepopulationsinleanandobesemice
AT mahatasushilk distincthepaticmacrophagepopulationsinleanandobesemice